Baseline NIH Stroke Scale Score predicting outcome in anterior and posterior circulation strokes

被引:232
作者
Sato, S. [1 ]
Toyoda, K. [1 ]
Uehara, T. [1 ]
Toratani, N. [1 ]
Yokota, C. [1 ]
Moriwaki, H. [1 ]
Naritomi, H. [1 ]
Minematsu, K. [1 ]
机构
[1] Natl Cardiovasc Ctr, Dept Med, Cerebrovasc Div, Osaka 5658565, Japan
关键词
D O I
10.1212/01.wnl.0000304346.14354.0b
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: The NIH Stroke Scale (NIHSS) may not appropriately assess the spectrum of posterior circulation (PC)-related neurologic deficits. We determined the cutoff baseline NIHSS score that predicts independent daily life activity during the chronic stage in anterior circulation (AC) vs PC ischemic strokes. Methods: A total of 310 consecutive patients hospitalized within 3 days after the onset of an ischemic stroke were prospectively enrolled in the study. Patients on thrombolytic therapy were excluded. In all patients, infarcts and vascular lesions were identified primarily using magnetic resonance techniques. A favorable outcome was defined as a modified Rankin Scale score of <= 2 at 3 months poststroke. Results: In 101 patients with PC stroke, the total baseline NIHSS score was lower (p < 0.001), and the subscores of ataxia (p < 0.001) and visual fields (p = 0.043) were higher than in 209 patients with AC stroke. Multivariate-adjusted OR for the favorable outcome in patients with PC vs AC stroke was 2.339 (95% CI 1.331-4.109, p = 0.003). A low baseline NIHSS score was independently predictive of a favorable outcome in both patients with PC (OR 1.547, 95% CI 1.232-1.941) and AC (1.279, 1.188-1.376) stroke. The optimal cutoff scores of the baseline NIHSS for the favorable outcome were <= 5 for patients with PC stroke (sensitivity, 84%; specificity, 81%) and <= 8 for patients with AC stroke (sensitivity, 80%; specificity, 82%). Conclusions: The cutoff score of the baseline NIH Stroke Scale (NIHSS) for a favorable chronic outcome was relatively low in patients with PC stroke compared to patients with AC stroke. The NIHSS appears to have limitations with respect to its use when comparing the neurologic severity of PC and AC stroke.
引用
收藏
页码:2371 / 2377
页数:7
相关论文
共 26 条
  • [1] Baseline NIH Stroke Scale score strongly predicts outcome after stroke - A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST)
    Adams, HP
    Davis, PH
    Leira, EC
    Chang, KC
    Bendixen, BH
    Clarke, WR
    Woolson, RF
    Hansen, MD
    [J]. NEUROLOGY, 1999, 53 (01) : 126 - 131
  • [2] CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL
    ADAMS, HP
    BENDIXEN, BH
    KAPPELLE, LJ
    BILLER, J
    LOVE, BB
    GORDON, DL
    MARSH, EE
    KASE, CS
    WOLF, PA
    BABIKIAN, VL
    LICATAGEHR, EE
    ALLEN, N
    BRASS, LM
    FAYAD, PB
    PAVALKIS, FJ
    WEINBERGER, JM
    TUHRIM, S
    RUDOLPH, SH
    HOROWITZ, DR
    BITTON, A
    MOHR, JP
    SACCO, RL
    CLAVIJO, M
    ROSENBAUM, DM
    SPARR, SA
    KATZ, P
    KLONOWSKI, E
    CULEBRAS, A
    CAREY, G
    MARTIR, NI
    FICARRA, C
    HOGAN, EL
    CARTER, T
    GURECKI, P
    MUNTZ, BK
    RAMIREZLASSEPAS, M
    TULLOCH, JW
    QUINONES, MR
    MENDEZ, M
    ZHANG, SM
    ALA, T
    JOHNSTON, KC
    ANDERSON, DC
    TARREL, RM
    NANCE, MA
    BUDLIE, SR
    DIERICH, M
    HELGASON, CM
    HIER, DB
    SHAPIRO, RA
    [J]. STROKE, 1993, 24 (01) : 35 - 41
  • [3] Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility
    Barber, PA
    Zhang, J
    Demchuk, AM
    Hill, MD
    Buchan, AM
    [J]. NEUROLOGY, 2001, 56 (08) : 1015 - 1020
  • [4] MEASUREMENTS OF ACUTE CEREBRAL INFARCTION - A CLINICAL EXAMINATION SCALE
    BROTT, T
    ADAMS, HP
    OLINGER, CP
    MARLER, JR
    BARSAN, WG
    BILLER, J
    SPILKER, J
    HOLLERAN, R
    EBERLE, R
    HERTZBERG, V
    RORICK, M
    MOOMAW, CJ
    WALKER, M
    [J]. STROKE, 1989, 20 (07) : 864 - 870
  • [5] Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset - The ATLANTIS study: A randomized controlled trial
    Clark, WM
    Wissman, S
    Albers, GW
    Jhamandas, JH
    Madden, KP
    Hamilton, S
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21): : 2019 - 2026
  • [6] Is the Association of National Institutes of Health Stroke Scale scores and acute magnetic resonance imaging stroke volume equal for patients with right- and left-hemisphere ischemic stroke?
    Fink, JN
    Selim, MH
    Kumar, S
    Silver, B
    Linfante, I
    Caplan, LR
    Schlaug, G
    [J]. STROKE, 2002, 33 (04) : 954 - 958
  • [7] NIHSS score and arteriographic findings in acute ischemic stroke
    Fischer, U
    Arnold, M
    Nedeltchev, K
    Brekenfeld, C
    Ballinari, P
    Remonda, L
    Schroth, G
    Mattle, HP
    [J]. STROKE, 2005, 36 (10) : 2121 - 2125
  • [8] Predicting prognosis after stroke - A placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial
    Frankel, MR
    Morgenstern, LB
    Kwiatkowski, T
    Lu, M
    Tilley, BC
    Broderick, JP
    Libman, R
    Levine, SR
    Brott, T
    [J]. NEUROLOGY, 2000, 55 (07) : 952 - 959
  • [9] INTERRATER RELIABILITY OF THE NIH STROKE SCALE
    GOLDSTEIN, LB
    BERTELS, C
    DAVIS, JN
    [J]. ARCHIVES OF NEUROLOGY, 1989, 46 (06) : 660 - 662
  • [10] The Desmoteplase In Acute Ischemic Stroke Trial (DIAS) - A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase
    Hacke, W
    Albers, G
    Al-Rawi, Y
    Bogousslavsky, J
    Davalos, A
    Eliasziw, M
    Fischer, M
    Furlan, A
    Kaste, M
    Lees, KR
    Soehngen, M
    Warach, S
    [J]. STROKE, 2005, 36 (01) : 66 - 73